logo
Plus   Neg
Share
Email

Biogen's Data Shows Improved Gastrointestinal Tolerability With Vumerity

Biogen Inc. (BIIB) said that the Phase 3 EVOLVE-MS-2 study demonstrated improved patient-assessed gastrointestinal or GI tolerability of Vumerity, a new FDA-approved treatment for relapsing forms of multiple sclerosis or MS, compared to Tecfidera.
Results for the primary endpoint show patients treated with Vumerity self-reported 46 percent fewer days with intensity scores of =2 on the Individual Gastrointestinal Symptom and Impact Scale (IGISIS), compared to Tecfidera.

The EVOLVE-MS-2 results also indicate that compared to TECFIDERA, VUMERITY-treated patients had lower discontinuations due to GI adverse events (AEs) (0.8 percent vs. 4.8 percent).

VUMERITY is now available in the U.S. for relapsing forms of MS.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Nestle Prepared Foods, part of Swiss food and beverage giant Nestle SA, has recalled around 762,615 pounds of not-ready-to-eat or NRTE pepperoni hot pockets as it might be contaminated with extraneous materials including glass and hard plastic, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. Lake Champlain Chocolates or LCC has recalled select LCC milk chocolate products citing the possible presence of foreign objects, mainly brittle plastic pieces, according to the U.S. Food and Drug Administration. The affected products include Hazelnut Five Star Bar; Fruit & Nut Five Star Bar; Almond Five Star Bar; Granola Five Star Bar... A public health alert has been issued for ready-to-eat or RTE beef jerky products by the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS. The warning is given due to misbranding and the presence of undeclared anchovies, a known allergen. A recall was not requested because the products are not currently available for sale to consumers.
Follow RTT